Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Non-radioactive label immunoprecipitation method for detecting specific self-antibody MDA5 of inflammatory myopathy

An autoantibody and immunoprecipitation technology, applied in the direction of virus/bacteriophage, recombinant DNA technology, biochemical equipment and methods, etc., can solve the problems of high false positive rate, high cost of ELISA kit, etc., and achieve easy transfection and high efficiency. Expressive, increased sensitivity effects

Inactive Publication Date: 2016-09-28
CENT SOUTH UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In view of this, this application aims at the above problems and provides a non-radiolabeled immunoprecipitation method and application for detecting inflammatory myopathy-specific autoantibody MDA5, which solves the problem that there is currently no commercial ELISA kit for detecting MDA5 antibodies in China As well as the problems of western blot strips, as well as the high cost, high false positive rate and safety of radiolabeled immunoprecipitation of ELISA kits coated with MDA5 antigen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-radioactive label immunoprecipitation method for detecting specific self-antibody MDA5 of inflammatory myopathy
  • Non-radioactive label immunoprecipitation method for detecting specific self-antibody MDA5 of inflammatory myopathy
  • Non-radioactive label immunoprecipitation method for detecting specific self-antibody MDA5 of inflammatory myopathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1 Non-radiolabeled immunoprecipitation method for detecting inflammatory myopathy-specific autoantibody MDA5

[0028] (1) Design primers MDA5-F (5'-TTCGGTCGACCAACAAAGAAGCAGTGTA-3') and MDA5-R (5'-GCGGTACCCTAATCCTCATCACTAAATAAACAG-3') to amplify the C-terminus of human MDA5 from the pENTER-MDA5 plasmid (Genbank: NM022168, 1743bp- 3479bp)( figure 1 a).

[0029] (2) Recover and purify the PCR fragment, perform double digestion with SalI and KpnI restriction endonucleases, connect overnight with the pCMV-myc vector that has been double-digested with SalI and KpnI, and transform JM109 bacteria competently, in the presence of 50ug / ml ampicillin Positive clones were screened on a penicillin plate, and the plasmid DNA of the positive clone was extracted in a small amount, and the plasmid DNA was digested with SalI and KpnI, and the results showed that the plasmid contained a 1.7kb insert ( figure 1 b).

[0030] (3) The plasmid DNA is sequenced to confirm the accuracy...

Embodiment 2

[0033] Example 2 detects the positive rate of the MDA5 antibody in the serum of 50 patients with inflammatory myopathy

[0034] (1) Inoculate 30% HEK293 cells on 75cm 2 37 culture dishes for less than 24 hours;

[0035] (2) Transfect HEK293 cells with 30ug pCMV-myc-MDA5C plasmid for 48 hours;

[0036] (3) HEK293 cells were lysed with 1 ml of RIPA lysate containing protease inhibitors, and the protein was quantified;

[0037](4) The c-myc antibody was used to confirm the overexpressed MDA5 C-terminus in HEK293 cells.

[0038] Take 20ul of the test serum, positive serum, negative serum and cell lysate overexpressing the MDA5 C-terminus of patients with inflammatory myopathy for immunoprecipitation, perform SDS-PAGE gel electrophoresis, and then detect with c-myc antibody to determine the MDA5 antibody The positive rate in patients with inflammatory myopathy is about 10% ( Figure 6 For some patients with inflammatory myopathy detected).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This application discloses a non-radiolabeled immunoprecipitation method for detecting inflammatory myopathy-specific autoantibody MDA5. The present invention provides the following method: constructing a plasmid containing the MDA5 C-terminus (447‑1025aa) and the N-terminus with a Myc tag HEK293 cells were transiently transfected with pCMV‑myc‑MDA5C, and serum from patients with inflammatory myopathy was immunoprecipitated with HEK293 cell lysates overexpressing the MDA5 C-terminus, followed by SDS‑PAGE gel electrophoresis and detection with c‑myc antibody Precipitated MDA5C-terminus solves the problem that there are no commercial ELISA kits for detecting MDA5 antibodies and western blot strips in China, as well as the high cost, high false positive rate and radiolabeling of ELISA kits that self-coat MDA5 antigens The safety of immunoprecipitation and other issues.

Description

technical field [0001] The application belongs to the field of biotechnology, and specifically relates to a non-radiolabeled immunoprecipitation method and application for detecting inflammatory myopathy-specific autoantibody MDA5. Background technique [0002] Idiopathic inflammatory myopathy (idiopathic inflammatory myopathies, IIM) is a group of systemic autoimmune diseases mainly invading skeletal muscle, the abnormality of autoimmunity is the key to the occurrence and development of IIM. According to the latest diagnostic classification criteria, IIM can be divided into polymyositis (PM), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM), non-specific muscle inflammation (nonspecific myositis, NSM) and inclusion body myositis (inclusion body myositis, sIBM). The clinical features of IIM are muscle weakness in the proximal extremities, characteristic rash, systemic damage, and the presence of various autoantibodies in the serum, which are closely related...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68G01N33/564C12N15/85C12N9/14
CPCG01N33/6854C12N9/14C12N15/85C12N2800/107C12Y306/04013G01N33/564G01N2800/10G01N2800/24
Inventor 张华莉王莉左晓霞朱红林罗卉李懿莎贺维佳刘可刘梅冬陈广文肖献忠
Owner CENT SOUTH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com